Intravenous injection of a foamy virus vector to correct canine SCID-X1Christopher R. Burtner, Hans‐Peter Kiem, Brian C. Beard et al.|Blood|2014Cited by 39
Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapyOlivier Humbert, Hans‐Peter Kiem, Troy R. Torgerson et al.|Blood Advances|2018Cited by 28
Pgk-Mediated Expression of Common Gamma Chain Is More Effective Than EF1a for Therapeutic Immune Reconstitution of X-SCID Dogs after In Vivo Gene Therapy with Foamy Virus VectorOlivier Humbert, Hans‐Peter Kiem, Christopher R. Burtner et al.|Blood|2015Cited by 1
Robust Therapeutic Expression of the Common Gamma Chain with the Human Pgk Promoter Using Foamy Virus in Vivo Gene Therapy in a Canine Model of Severe Combined ImmunodeficiencyChristopher R. Burtner, Hans‐Peter Kiem, Olivier Humbert et al.|Blood|2014Cited by 0
441. Direct Comparison of EF1α and PGK Promoters Reveals Superior Performance of the PGK Promoter for Expression of the Common Gamma Chain in a Canine Model of In Vivo Foamy Virus Gene Therapy for Severe Combined ImmunodeficiencyChristopher R. Burtner, Hans‐Peter Kiem, Olivier Humbert et al.|Molecular Therapy|2015Cited by 0